97 related articles for article (PubMed ID: 29974375)
1. Increased Plasma Nitrite and von Willebrand Factor Indicates Early Diagnosis of Vascular Diseases in Chemotherapy Treated Cancer Patients.
Giri S; Bose JC; Chandrasekar A; Tiwary BK; Gajalakshmi P; Chatterjee S
Cardiovasc Toxicol; 2019 Feb; 19(1):36-47. PubMed ID: 29974375
[TBL] [Abstract][Full Text] [Related]
2. Clinical and In Vitro Evidence That Left Ventricular Assist Device-Induced von Willebrand Factor Degradation Alters Angiogenesis.
Bartoli CR; Zhang DM; Hennessy-Strahs S; Kang J; Restle DJ; Bermudez C; Atluri P; Acker MA
Circ Heart Fail; 2018 Sep; 11(9):e004638. PubMed ID: 30354363
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of plasma von Willebrand factor levels in major adverse cardiovascular events: a systematic review and meta-analysis.
Fan M; Wang X; Peng X; Feng S; Zhao J; Liao L; Zhang Y; Hou Y; Liu J
BMC Cardiovasc Disord; 2020 Feb; 20(1):72. PubMed ID: 32039706
[TBL] [Abstract][Full Text] [Related]
4. von Willebrand factor and its relevance to cardiovascular disorders.
Lip GY; Blann AD
Br Heart J; 1995 Dec; 74(6):580-3. PubMed ID: 8541159
[TBL] [Abstract][Full Text] [Related]
5. Vascular fingerprint and vascular damage markers associated with vascular events in testicular cancer patients during and after chemotherapy.
Lubberts S; Boer H; Altena R; Meijer C; van Roon AM; Zwart N; Oosting SF; Kamphuisen PW; Nuver J; Smit AJ; Mulder AB; Lefrandt JD; Gietema JA
Eur J Cancer; 2016 Aug; 63():180-8. PubMed ID: 27322917
[TBL] [Abstract][Full Text] [Related]
6. Association between brain-derived neurotrophic factor and von Willebrand factor levels in patients with stable coronary artery disease.
Jin H; Chen Y; Wang B; Zhu Y; Chen L; Han X; Ma G; Liu N
BMC Cardiovasc Disord; 2018 Feb; 18(1):23. PubMed ID: 29409455
[TBL] [Abstract][Full Text] [Related]
7. von Willebrand Factor-Rich Platelet Thrombi in the Liver Cause Sinusoidal Obstruction Syndrome following Oxaliplatin-Based Chemotherapy.
Nishigori N; Matsumoto M; Koyama F; Hayakawa M; Hatakeyayama K; Ko S; Fujimura Y; Nakajima Y
PLoS One; 2015; 10(11):e0143136. PubMed ID: 26580395
[TBL] [Abstract][Full Text] [Related]
8. Microalbuminuria, von Willebrand factor and fibrinogen levels as markers of the severity in COPD exacerbation.
Polatli M; Cakir A; Cildag O; Bolaman AZ; Yenisey C; Yenicerioglu Y
J Thromb Thrombolysis; 2008 Oct; 26(2):97-102. PubMed ID: 17622488
[TBL] [Abstract][Full Text] [Related]
9. Von Willebrand factor could be an index of endothelial dysfunction in patients with cirrhosis: relationship to degree of liver failure and nitric oxide levels.
Albornoz L; Alvarez D; Otaso JC; Gadano A; Salviú J; Gerona S; Sorroche P; Villamil A; Mastai R
J Hepatol; 1999 Mar; 30(3):451-5. PubMed ID: 10190728
[TBL] [Abstract][Full Text] [Related]
10. Gastric cancer-associated enhancement of von Willebrand factor is regulated by vascular endothelial growth factor and related to disease severity.
Yang X; Sun HJ; Li ZR; Zhang H; Yang WJ; Ni B; Wu YZ
BMC Cancer; 2015 Feb; 15():80. PubMed ID: 25886574
[TBL] [Abstract][Full Text] [Related]
11. Detection of early endothelial damage in patients with Raynaud's phenomenon.
Gualtierotti R; Ingegnoli F; Griffini S; Grovetti E; Borghi MO; Bucciarelli P; Meroni PL; Cugno M
Microvasc Res; 2017 Sep; 113():22-28. PubMed ID: 28450106
[TBL] [Abstract][Full Text] [Related]
12. An ELISA for the quantitation of von Willebrand factor: osteoprotegerin complexes in plasma.
Vinholt PJ; Overgaard M; Diederichsen AC; Mickley H; Poulsen TS; Sand NP; Nybo M; Rasmussen LM
Thromb Res; 2013 May; 131(5):396-400. PubMed ID: 23531238
[TBL] [Abstract][Full Text] [Related]
13. Profile of von Willebrand factor antigen and von Willebrand factor propeptide in an overall TIA and ischaemic stroke population and amongst subtypes.
Tobin WO; Kinsella JA; Kavanagh GF; O'Donnell JS; McGrath RT; Tierney S; Egan B; Feeley TM; Coughlan T; Collins DR; O'Neill D; Murphy S; Lim SJ; Murphy RP; McCabe D
J Neurol Sci; 2017 Apr; 375():404-410. PubMed ID: 28320178
[TBL] [Abstract][Full Text] [Related]
14. The predictive value of Von Willebrand factor antigen plasma levels in children with acute lung injury.
El Basset Abo El Ezz AA; Abd El Hafez MA; El Amrousy DM; El Momen Suliman GA
Pediatr Pulmonol; 2017 Jan; 52(1):91-97. PubMed ID: 27362747
[TBL] [Abstract][Full Text] [Related]
15. A new method measuring the interaction between von Willebrand factor and coagulation factor VIII.
Karlman M; Holmström M; Wiman B
Thromb Res; 2011 Jan; 127(1):47-50. PubMed ID: 21094987
[TBL] [Abstract][Full Text] [Related]
16. Von Willebrand Factor, ADAMTS13, and the Risk of Mortality: The Rotterdam Study.
Sonneveld MA; Franco OH; Ikram MA; Hofman A; Kavousi M; de Maat MP; Leebeek FW
Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2446-2451. PubMed ID: 27737864
[TBL] [Abstract][Full Text] [Related]
17. Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma.
Lippi G; Franchini M; Salvagno GL; Montagnana M; Poli G; Guidi GC
J Thromb Thrombolysis; 2008 Oct; 26(2):150-3. PubMed ID: 17786534
[TBL] [Abstract][Full Text] [Related]
18. Von Willebrand factor in relation to coronary plaque characteristics and cardiovascular outcome. Results of the ATHEROREMO-IVUS study.
Sonneveld MA; Cheng JM; Oemrawsingh RM; de Maat MP; Kardys I; Garcia-Garcia HM; van Geuns RJ; Regar E; Serruys PW; Boersma E; Akkerhuis KM; Leebeek FW
Thromb Haemost; 2015 Mar; 113(3):577-84. PubMed ID: 25472874
[TBL] [Abstract][Full Text] [Related]
19. siRNA-knockdown of ADAMTS-13 modulates endothelial cell angiogenesis.
Tang H; Lee M; Kim EH; Bishop D; Rodgers GM
Microvasc Res; 2017 Sep; 113():65-70. PubMed ID: 28546076
[TBL] [Abstract][Full Text] [Related]
20. 5-fluorouracil-based therapy induces endovascular injury having potential significance to development of clinically overt cardiotoxicity.
Jensen SA; Sørensen JB
Cancer Chemother Pharmacol; 2012 Jan; 69(1):57-64. PubMed ID: 21603868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
